Bob has been recognized as a thought leader in healthcare business consulting for over 30 years. He has led strategy development and supervised opportunity assessments for hundreds of clients on 4 continents, including large and specialty pharmaceutical companies, early-stage through publicly traded biopharmaceutical companies, and diagnostics businesses.
Prior to Bionest, Bob built and led two consulting firms, The Wilkerson Group and Easton Associates. He brings powerful analytical skills to bear on projects to ensure insightful and actionable results. Bob applies his deep domain knowledge to influence the decision-making of medical industry leaders and support client executives around the world.
Over his long career, Bob has written and spoken about multiple industry issues in scores of venues. He is Chairman of the New York Biotechnology Association, and has served on 8 medical company Boards. He also serves as Chairman of Gilda’s Club of New York City, which provides social and emotional support to people living with cancer.
Bob holds 2 degrees in Chemical Engineering from Rice University and an MBA from the Harvard Business School.